$10.78+144.89% · 3M
Moving avg
1W+55.48%
1M+59.87%
3M+163.45%
6M+247.58%
YTD+214.14%
1Y+139.44%
3Y+92.75%
5Y-38.99%
52-week range
$2.75100% of range$10.01
Company health
Value0/6
Growth6/6
Profitability1/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Revenue compounding 36% a year
Risks
- Trades 26% above the average analyst target
- Currently unprofitable
- Burning free cash flow
Key statistics
Valuation
Market cap
$3.29B
Enterprise value
$2.87B
P/E ratio (TTM)
-17.30x
P/S ratio (TTM)
43.10x
EV/EBITDA
-17.89x
Per share & returns
EPS (TTM)
-$0.54
Dividend yield
0.00%
Beta (1Y)
1.19
30-day change
+59.87%
Trading
Volume (24h)
11.32M
Previous close
$10.36
Shares outstanding
305.38M
About AbCellera Biologics Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
ABCL
AbCellera Biologics Inc. is a mid-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (Canada) and trade under the ticker ABCL.
Frequently asked questions
What is AbCellera Biologics Inc.'s market cap?
AbCellera Biologics Inc. (ABCL) has a market capitalization of $3.29B.
What sector is AbCellera Biologics Inc. in?
AbCellera Biologics Inc. operates in the Healthcare sector, Biotechnology industry.
What exchange does ABCL trade on?
ABCL trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,216.14-0.34%
$1.15T cap
Johnson & JohnsonJNJ
$261.40+0.21%
$629.95B cap
AbbVie Inc.ABBV
$250.91+0.86%
$443.31B cap
UnitedHealth Group IncorporatedUNH
$402.02-0.88%
$365.09B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.82+1.43%
$332.98B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap